| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.48M | - | |
| CFO | 58.4K | $16.60M | - | |
| VP | 29.8K | $8.46M | - | |
| VP | 23.7K | $6.73M | - | |
| Dir | 23.2K | $6.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2020 | Vaishnaw Akshay56 | President, R&D | Sale+OE | 970 | $151.07 | $146,535.74 | -1.3% | |
| May 20, 2020 | Maraganore John | Chief Executive Officer | Sale+OE | 34,765 | $143.22 | $4,978,983.06 | -5.3% | |
| May 6, 2020 | Greene Barry E | President | Sale+OE | 22,265 | $149.99 | $3,339,527.35 | -26.3% | |
| May 6, 2020 | Greenstreet Yvonne49 | Chief Operating Officer | Sale+OE | 57,811 | $148.65 | $8,593,540.00 | -85.7% | |
| Apr 20, 2020 | Keating Laurie55 | EVP, Chief Legal Officer | Sale+OE | 10,000 | $139.00 | $1,390,000.00 | -40.8% | |
| Apr 20, 2020 | Vaishnaw Akshay56 | President, R&D | Sale+OE | 21,971 | $140.00 | $3,075,940.00 | -60.9% | |
| Feb 20, 2020 | Maraganore John | Chief Executive Officer | Sale+OE | 34,765 | $131.85 | $4,583,674.29 | -2.7% | |
| Feb 12, 2020 | Sharp Phillip A45 | Director | Sale+OE | 30,000 | $130.00 | $3,900,000.00 | -11.3% | |
| Feb 10, 2020 | Keating Laurie55 | EVP, Chief Legal Officer | Sale+OE | 10,000 | $129.00 | $1,290,000.00 | -44.9% | |
| Feb 10, 2020 | Paul Steven M | Director | Sale+OE | 30,000 | $130.00 | $3,900,000.00 | -96.8% |